Haemonetics (HAE) Shares Issued (2009 - 2025)

Haemonetics has reported Shares Issued for 17 years, with the latest figure at $1.1 million in Q4 2025.

• For the quarter ending Q4 2025, Shares Issued rose 127.13% year-over-year to $1.1 million; the trailing twelve-month figure through Dec 2025 stood at $2.2 million (up 19.48% YoY), and the FY2024 full-year result was $1.6 million, down 38.97% from the prior year.
• Shares Issued for Q4 2025 stood at $1.1 million, up from $63000.0 in the prior quarter.
• The five-year high for Shares Issued was $2.4 million in Q2 2021, with the low at $63000.0 in Q3 2025.
• Average Shares Issued over 5 years is $650210.5, with a median of $462000.0 recorded in 2025.
• Year-over-year, Shares Issued surged 1519.7% in 2021 and sank 86.27% in 2022.
• Tracing HAE's Shares Issued over 5 years: stood at $1.1 million in 2021, then sank by 85.03% to $160000.0 in 2022, then grew by 16.25% to $186000.0 in 2023, then surged by 171.51% to $505000.0 in 2024, then jumped by 127.13% to $1.1 million in 2025.
• The last three Shares Issued figures came in at $1.1 million (Q4 2025), $63000.0 (Q3 2025), and $462000.0 (Q2 2025), per Business Quant data.

Peer Comparison